Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
Article excerpt
Highlighted: the sentence this signal was extracted from
Bio-Techne partners with the Wyss Center Geneva to advance automated 3D multiomics technology and accelerate Spatial Biology. * Collaboration aims to automate RNA and protein detection in 3D tissue specimens, reducing complexity and technical barriers. * Innovation has the potential to improve preclinical research by reducing reliance on animal testing through New Approach Methodologies (NAMs) such as organoids and predictive modeling, enabling new directions and scale in advanced biomedical studies. * Partnership underscores Bio-Techne's commitment to drive innovation and accelerate the broad adoption of spatial biology. MINNEAPOLIS, Dec. 11, 2025 /PRNewswire/ - Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced a strategic collaboration between one of its spatial biology brands, Lunaphore, and the Wyss Center for Bio and Neuroengineering (Wyss Geneva) to develop an automated workflow for simultaneous RNA and protein detection in 3D specimens. The project will enable high-resolution multiomic analysis within intact 3D samples. Bio-Techne's current multiomic spatial biology technologies deliver unparalleled insights in 2D, enabling breakthroughs in disease research and therapeutic development. The Wyss initiative aims to extend these capabilities into 3D, unlocking an even deeper understanding...
Keep reading with a free account
The rest of this article, and every signal for Bio-Techne, is in your free account.
